Dow Down 0.32% Nasdaq Down 0.62%

ChemoCentryx, Inc. (CCXI)

-NasdaqGS
2.40 Down 0.04(1.64%) Apr 29, 4:00PM EDT
|After Hours : 2.40 0.00 (0.00%) Apr 29, 4:35PM EDT
Prev Close:2.44
Open:2.43
Bid:2.26 x 3600
Ask:3.60 x 300
1y Target Est:11.00
Beta:1.36231
Earnings Date:May 4 - May 9 (Est.)
Day's Range:2.37 - 2.54
52wk Range:2.16 - 9.46
Volume:107,863
Avg Vol (3m):222,757
Market Cap:106.30M
P/E (ttm):N/A
EPS (ttm):-1.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CCXI

Comparison

Symbol% ChgMkt Cap
CCXIDown 1.64%106.30M
ABTDown 3.76%57.31B
AZNDown 1.06%73.21B
AMGNDown 1.41%118.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.02
Quarterly EPS Est (Mar-16) :-0.27
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat orphan and rare diseases, autoimmune diseases, inflammatory disorders, and ca... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback